↓ Skip to main content

Cyclo-oxygenase (COX) inhibitors for preventing preterm labour

Overview of attention for article published in Cochrane database of systematic reviews, October 2012
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cyclo-oxygenase (COX) inhibitors for preventing preterm labour
Published in
Cochrane database of systematic reviews, October 2012
DOI 10.1002/14651858.cd007748.pub2
Pubmed ID
Authors

Thirawut Khanprakob, Malinee Laopaiboon, Pisake Lumbiganon, Ussanee S Sangkomkamhang

Abstract

Preventing preterm labour is the most important step in preventing preterm birth. Prostaglandins play an important role in labour and birth. Prostaglandin production can be obstructed by inhibition of the cyclo-oxygenase (COX) enzyme and this may arrest uterine contraction. A Cochrane review on COX inhibitors for the treatment of preterm labour found insufficient data to draw conclusions about its effectiveness.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 3%
Ethiopia 1 3%
South Africa 1 3%
United Kingdom 1 3%
Ireland 1 3%
Netherlands 1 3%
Unknown 26 81%

Demographic breakdown

Readers by professional status Count As %
Student > Master 43 134%
Unspecified 40 125%
Student > Ph. D. Student 35 109%
Researcher 27 84%
Student > Bachelor 21 66%
Other 54 169%
Readers by discipline Count As %
Medicine and Dentistry 108 338%
Unspecified 41 128%
Nursing and Health Professions 18 56%
Pharmacology, Toxicology and Pharmaceutical Science 12 38%
Psychology 10 31%
Other 31 97%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2012.
All research outputs
#11,143,407
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#8,923
of 8,923 outputs
Outputs of similar age
#118,636
of 139,550 outputs
Outputs of similar age from Cochrane database of systematic reviews
#83
of 86 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 139,550 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.